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In this review, recent advances on the development of electronic detection methodologies based on non-antibody 
recognition elements such as functional liposomes, aptamers and synthetic peptides are discussed. Particularly, we 
highlight the progress of field effect transistor (FET) sensing platforms where possible as the number of publications on 
FET-based platforms has rapidly increased. Biosensors involving antibody-antigen interactions have been widely applied in 
diagnostics and healthcare in virtue of superior selectivity and sensitivity, which can be attributed to their high binding 
affinity and extraordinary specificity, respectively. However, antibodies are typically suffering from fragile and complicated 
functional structures, large molecular size and sophisticated preparation approaches (resource-intensive and time-
consuming), resulting in limitations such as short shelf-life, insufficient stability and poor reproducibility. Recently, bio-
sensing approaches based on synthetic elements have been intensively explored in recent years. In contrast to existing 
reports, this review provides a comprehensive overview on recent advances in development of biosensors utilizing 
synthetic recognition elements and a detailed comparison of their assay performances. Therefore, this review would serve 
as a good summary of the efforts on development of electronic bio-sensing approaches involving synthetic recognition 
elements.  
Introduction 
As analytical devices used for detections of various biological 
analyte,
1
 biosensors have been extensively investigated and 
applied in various fields such as environmental protection,
2, 3
 
food safety,
4, 5
 and healthcare.
6-8
 Due to the great 
achievements in this field, the world market for commercial 
biosensors reached 12 billion US dollars in 2011 and is 
expected to exceed 16 billion US dollars in 2018.
1
 Among all 
sensing approaches reported, assays based on electronic 
platforms have attracted increasing attention. The number of 
articles referencing ‘electronic biosensor’ published in a year 
has been increasing steadily over the past decade (Fig. 1a). 
Particularly, assays using field-effect transistor (FET) sensing 
platforms have been intensively studied and widely applied in 
virtue of their superior sensitivity,
9, 10
 good compatibility with 
microfabrication processes,
11
 and potential for 
miniaturization.
12
 Indeed, over 40% of all articles related to 
electronic biosensors involved FET-based platforms and 
publications referencing ‘FET biosensor’ exceeded 3500 in 
2014. The general configuration of a FET device (Fig. 1b) 
includes a source electrode, a drain electrode and a gate 
electrode. The current from source to drain (Id) is modulated 
by the voltage on gate (Vg). In FET sensing processes, 
molecular binding events in the gate region leads to a change 
in the conductance of the transducing layer, which could be 
correlated to the concentration of analytes.
13
  
Conventionally, most sensing approaches are based on natural 
biomolecular pairs such as antibody/antigen due to their 
superior binding affinity and selectivity.
14, 15
 Biosensors based 
on these approaches have been intensively studied and widely 
applied in diagnostics and healthcare. Nevertheless, several 
limitations have also been observed for the sensing 
approaches based on natural biomolecular pairs. Firstly, the 
functional structures of natural biomolecules such as 
antibodies are typically complicated and fragile. Hence, 
denaturation/deactivation of these molecules can be readily 
triggered by exposure to typical working environments of 
biosensors.
16
 Meanwhile, these natural biomolecules usually 
exhibit large molecular sizes, which may significantly 
contribute to steric hindrance of target molecules in the 
sensing process.
17, 18
 Large molecular size further limits the 
quantity of receptors immobilized per unit area.
19
 Additionally, 
preparations of natural biomolecules are typically resource-
intensive and time-consuming, resulting in high cost of 
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biosensors based on these approaches.
20
 Therefore, practical 
applications of biosensors based on natural biomolecular pairs 
have been limited by issues such as short shelf-life, insufficient 
stability and poor reproducibility. Over the past few decades, 
efforts have been devoted to exploration of sensing 
approaches that are not based on conventional natural 
biomolecular pairs. 
To date, a variety of synthetic molecules have been proposed 
as alternative recognition elements to the natural 
biomolecules in conventional bio-sensing assays. Among these 
options, liposomes,
21
 aptamers 
22
 and peptides 
23
 have been 
intensively explored and widely applied. In response to 
increasing attentions to alternative recognition elements, 
several reviews summarizing biosensors based on synthetic 
recognition elements have been published.
16, 23-25
 These 
articles summarized advances in the study of detection 
mechanism, described recent cases and typically included 
comparisons of detection methodologies such as electronic 
methods, optical methods, quartz crystal microbalance-based 
methods, utilizing one particular class of synthetic recognition 
element.  However, a comprehensive summary of assay 
performances of different synthetic recognition elements 
would be necessary for the evaluation of their applicability for 
biosensing. This article therefore offers an overview of the 
development of electronic biosensors based on non-antibody 
recognition elements. More specifically, the most recent 
advances on different categories of non-antibody recognition 
elements (including liposomes, aptamers and peptides) were 
highlighted, followed by individual discussions on the 
development of electronic biosensors based on each category 
of non-antibody recognition elements. Meanwhile, biosensors 
based on different categories of non-antibody recognition 
elements were compared with each other to facilitate 
understanding of their respective pros and cons. Table 1 
summarizes recent advances in sensing assays based on 
recognition elements mentioned above. The target analyte, 
limit of detection achieved, methodology used and 
characteristics of these assays are presented. Table 1 
illustrates that, irrespective of the methodology adopted, 
assays based on synthetic recognition elements have exhibited 
the capability to detect various analytes (including enzyme, 
virus, DNA and bacteria) at clinically relevant concentrations. 
 
Fig. 1 (a) A search of publications referencing ‘electronic biosensor’ and ‘field-effect transistor biosensor’ over the past decade, using Google Scholar. Steady increases 
have been observed for both topics. The publications related to electronic biosensors exceeded 8000 in 2014 and around 40% of these studies involved FET-based sensing 
platforms. (b) General configuration of an FET-based sensing platform. Capture of analyte by the recognition element can generate a change in the source-drain current or 
potential, which can be detected as a signal. 
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Table 1. A comparison of various synthetic recognition elements (liposomes, aptamers and peptides) for electronic bio-sensing applications. 
Recognition 
elements 
Target analyte Limit of detection Methodology Characteristics 
Liposomes Human immunodeficiency 
virus 26 
6.7 x 1011 /μl Impedance spectroscopy Pros 
 Signal amplification via reporter encapsulation 
 Rapid and label-free detection 
 High specificity 
 
Cons 
 Tedious selection and modification process 
required 
Nuclei acid sequences 27 12.5 μM Amperometric detection 
Glucose 28, 29 40 mM Cyclic voltammetry 
Glucose 30 8.6 ± 1.1 μM Amperometric detection 
Organophosphate 31 0.68 ± 0.076 μg/L Amperometric detection 
Escherichia coli (E. coli) 32 100 cfu/mL Amperometric detection 
Phospholipase A2 
33 80 pM  Amperometric detection 
Aptamers Oligonucleotides (DNA) 34 2-5 nM Potentiometric sensing Pros 
 Good reproducibility 
 Excellent stability in harsh environments 
 Reversible aptamer/target interactions 
 
Cons 
 Sensitivity to hydrolytic digestion by nucleases 
Adenosine 35 50 μM Potentiometric sensing 
Immunoglobulin E (IgE) 36 250 pM Amperometric detection 
HIV-1 Tat protein 37 < 1 nM Amperometric detection 
ATP 38 < 10 nM Potentiometric sensing 
Adenosine 38 1-10 nM Potentiometric sensing 
Lysozyme 39 12 nM Potentiometric sensing 
Thrombin 39 6.7 nM Potentiometric sensing 
Thrombin 40 5.5 nM Potentiometric sensing 
Matrilysin (MMP-7) 41 3.4 pM Cyclic voltammetry 
Peptides Trypsin and α-Thrombin 
(protease) 42 
1 nM Cyclic voltammetry Pros 
 High binding affinity 
 Excellent stability in harsh environments 
 Facile and cost-effective synthesis 
 
Cons 
 Signal marker labelling required in some cases 
 Moderate selectivity due to their semi-
selective nature 
Escherichia coli (E. coli) 43 100 cfu/mL Impedance spectroscopy 
C-creative protein (CRP) 44 0.1 μg/L Impedimetric sensing 
MMP-7 10 ng/mL Amperometric detection 
   
Liposome-based sensing approaches 
Liposomes are self-assembled microscopic vesicles prepared 
by the hydration of lipid thin film.
45-47
 As shown in Fig. 2, these 
artificially-prepared vesicles contain an inner aqueous 
compartment surrounded by a lipid bilayer (i.e. phospholipids 
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and sterols), resulting in hydrophilic interior and exterior.
48
 
Due to their unique structures, liposomes can encapsulate any 
water-soluble molecules or nanoparticles (e.g. enzymes, nuclei 
acids, chemical molecules, fluorescent dyes). In the presence 
of certain molecules/rays or changes in the environment, 
rupture of liposomes are triggered and encapsulants are 
released.
49, 50
 Phospholipids, the basic units of liposomes, 
exhibit distinctive advantages such as non-toxicity, 
biodegradability and good biocompatibility. Therefore, 
liposomes have been applied in drug delivery (as carriers),
51, 52
 
food science,
53
 and bio-sensing (as recognition elements).
33
 
Particularly, the application of liposomes in bio-sensing has 
attracted increasing attention. Previously, liposomes were 
used as carriers of optical indicators in assays based on 
fluorescence,
54
 surface plasmon resonance (SPR),
55
 and 
colorimetric changes.
56
 These optical approaches were facile, 
rapid yet effective.
57-59
 However, assays based on optical 
methodologies are inherently limited by insufficient sensitivity, 
cross-talk issues (especially in fluorescence-based assays) and 
requirement for sophisticated instrumentation. Therefore, 
recent efforts have been made to integrate liposomes with 
other detection methods. Combined with effective 
transduction methodologies such as electronic transductions, 
liposomes can be used for molecular detections with ultra-high 
sensitivity,
33
 which can be attributed to the significant signal 
amplification realized by appropriate reporters.
60
 
 
Fig. 2 Schematic illustration of unilamellar liposome. Hydrophilic molecules are 
encapsulated in the liposome, thus being separated from the solvent outside. 
(From Chen et al.,61 with permission from SciencePG) 
Liposome-based assays for detections of various analytes (e.g. 
enzymes, viruses and nuclei acids) have been reported. For 
instance, Damhorst et al. introduced an assay using ions as 
reporters.
26
 In this study, ion-encapsulated dipalmitoyl-
phosphatidylcholine (DPPC) liposomes were employed for 
electronic detection of viruses. In virtue of the portable 
impedance sensing platform used, this assay exhibited great 
potential for point-of-care diagnostic applications. Additionally, 
this assay may be adapted for viral detections using liposomes 
as recognition elements upon appropriate selection or 
modification of liposomes. Wongkaew et al. reported an 
amperometric detection of chemical molecules on a 
microfluidic channel.
27
 Herein, specific nuclei acid sequences 
were measured quantitatively using ferri/ferro hexacyanide-
encapsulated liposomes. Fast (within 5 min) and sensitive (LOD 
= 12.5 μM), this assay is suitable for diagnostics and healthcare 
applications. Taylor et al. presented an assay for quantitative 
detection of glucose using a liposomal enzyme electrode. 
Glucose oxidases were encapsulated in liposomes and the 
glucose molecules were detected using a cyclic voltammetry 
related methodology. A linear response to glucose up to 40 
mM was achieved using this assay (Fig. 3a).
28
 Similarly, Graça 
et al. presented an amperometric glucose biosensor based on 
glucose oxidase (GOx)-encapsulated liposomes.
30
 Herein, GOx 
were encapsulated in liposomes to preserve their native 
structures (Fig. 3b). The sensitivity of this assay was 7.5 times 
higher than that of its peers using non-encapsulated GOx. 
Additionally, the proposed assay showed a sensitivity that was 
significantly higher than previous assays. Yan et al. described 
an assay for detections of organophosphate pesticides 
residues.
31
 In this assay, acetylcholinesterase (AChE) molecules 
were encapsulated in phosphatidylcholine liposomes and the 
porin-embedded lipid membrane allows in pesticide only. The 
current change was generated by the inhibition reaction of 
organophosphate pesticides by AChE. Nevertheless, liposomes 
were not functioning as recognition elements in assays 
mentioned above. Instead, they were either used as carriers 
(to screen out other molecules or preserve the natural 
structure of encapsulants) or tagged with a reporter probe 
that hybridizes with the target. 
More recently, efforts have been made to explore the 
capability of liposome as recognition element in electronic 
detections. Zhang et al. reported an amperometric detection 
of Escherichia coli (E. coli) using 4-nitrophenyl β-D-glucuronide 
(PNPG) as the recognition element.
32
 β-D-glucuronide released 
from E. coli catalysed the hydrolysis of PNPG to produce 4-
nitrophenyl and the concentration of these electroactive 
molecules is proportional to that of E. coli. Detection of E. coli 
ranging from 1.5 × 10
2
 to 1.0 × 10
6
 cfu/mL was demonstrated 
and the LOD achieved was 100 cfu/mL. Chen et al. reported a 
liposome-based enzymatic assay for the detection of 
phospholipase A2 (Fig. 3c).
33
 In this assay, 2,4,6-trinitrophenol 
molecules (TNPs, used as reporter) were encapsulated in 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) 
liposomes. In the presence of target enzymes, rupture of 
liposomes was triggered and the reporter molecules were 
released. Once diffused to the surface of reduced graphene 
oxide (rGO), TNPs adsorb on rGO via π-π interactions and 
modulate the conductance of the transducing layer due to the 
presence of electron withdrawing NO2 groups.
62
 Besides the 
sensitive nature of electronic biosensors, signal enhancement 
by the excess concentration of reporter molecules 
encapsulated also made a great contribution to the superior 
sensitivity of this assay. Additionally, this approach could be 
extended for detections of other lipid-degrading enzymes or 
membrane toxins. 
Nevertheless, it is notable that liposomes suffer from tedious 
selection and modification process.
45
 and many liposome-
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based assays have an issue of low on/off ratio, which could be attributed to encapsulant leakage. 
 Fig. 3 (a) Configuration of oxygen electrode used with a liposome impregnated membrane. (From Taylor et al.,28 with permission from Elsevier) (b) Schematic illustration of the 
detection mechanism involved in amperometric glucose biosensor based on glucose oxidase (GOx)-encapsulated liposomes. (From Graça et al.,30 with permission from Elsevier) (c) 
Reporter-encapsulated POPC liposomes on reduced graphene oxide based field-effect transistor (FET). Rupture of liposomes, which is triggered by the target enzyme, 
leads to release of TNP molecules, which then adsorb on graphene surface and modulate Id. (From Chen et al.,
33 with permission from Royal Society of Chemistry) 
Aptamer-based sensing approaches 
In bio-sensing applications, aptamers are defined as selected 
single-stranded nucleic acid ligands (DNA or RNA) with high 
binding affinity and specificity to the target analyte (e.g. 
protein and inorganic molecules).
63, 64
 Attributed to the folding 
capability upon binding,
65
 the binding affinity and specificity of 
aptamer/target interactions are comparable to that of 
antibody/antigen interactions. Hence, nucleic acid aptamers 
are termed as “chemical antibodies” in various cases.
66, 67
 In 
virtue of unprecedented advantages over natural receptors, 
aptamers have attracted increasing attention in diagnostics 
and healthcare.
68-71
 For instance, most aptamer-based 
biosensors exhibit good reproducibility thanks to the well-
established chemical synthesis routes.
24
 Currently, most 
aptamers are obtained by the systematic evolution of ligands 
by exponential enrichment (SELEX) process (Fig. 4).
72, 73
 Firstly, 
a huge nuclei acid library is created and incubated with the 
target molecule/ligand. The unbound sequences and 
molecules are removed, while the bound nuclei acids are 
eluted and amplified by polymerase chain reaction (PCR). As a 
result, an enriched library is obtained and this new library is 
used as the starting library in the next cycle. After 6–12 
consecutive cycles, the final library is cloned and sequenced.
24, 
74
 The in vitro selection of aptamers eliminates the need for in 
vivo immunization of animals, as in the case of antibody 
production. Additionally, aptamers can be chemically 
synthesized in an easy and reproducible manner once the 
sequence is obtained using SELEX. Unlike natural biomolecules, 
aptamers exhibit excellent stability in harsh environments and 
are not subject to denaturization, thus suitable for clinical 
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applications.
75
 More importantly, significant conformational 
changes can be observed for aptamers upon target binding, 
demonstrating great potential for ultra-sensitive assays.
24, 76
 
Interactions between aptamers and target molecules could be 
reversed by reversible intermolecular hybridizations,
77
 
indicating a great potential for development of non-disposable 
biosensors. Additionally, non-specific adsorptions on nucleic 
acid interfaces are usually reduced compared with protein 
interfaces. 
Nevertheless, it should be noted that aptamers, especially RNA 
ones, are readily digested by nucleases.
78
 Therefore, it is 
necessary to reduce concentrations of nucleases to negligible 
levels for proper functioning of aptamer-based assays. 
 
Fig. 4 Schematic of systematic evolution of ligands by exponential enrichment (SELEX) process. A huge nuclei acid library is created and incubated with the target 
molecule/ligand. Unbound sequences and molecules are removed, while bound ones are eluted and amplified by polymerase chain reaction (PCR) to form an enriched library, 
which is used as the starting library in the next cycle. Generally, 6–12 consecutive cycles are performed for each target and the final library is cloned and sequenced.24, 74 
To date, aptamers-based assays have been intensively 
explored and widely applied. Fritz et al. described an ultra-
selective and label-free assay for DNA detection.
34
 Herein, 
complementary DNA sequences adsorbed on micro-fabricated 
FET were used as the recognition element. The LOD achieved 
by this assay was 2-5 nM. Additionally, this assay achieved the 
detection of a single base mismatch within 12-mer 
oligonucleotides, demonstrating excellent specificity. Zayats et 
al. monitored the binding of adenosine (molecule with a 
relatively low molecular weight) to its corresponding 
aptamer.
35
 An amino-functionalized nucleic acid (named 
nucleic acid 5 in the study) was used as the aptamer and 
another nucleic acid (named nucleic acid 6 in the study) was 
hybridized with the aptamer. The introduction of adenosine 
triggered the displacement of nucleic acid 6, resulting in 
changes of the local charge associated with the gate potential 
(Fig. 5a). This assay exhibited high specificity (negligible 
responses to other nucleotides such as cytidine), while the 
sensitivity was relatively poor (detection limit = 50 µM). 
Maehashi et al. reported an aptamer-modified carbon 
nanotube field-effect transistor (CNT-FET) for the detection of 
immunoglobulin E (IgE).
36
 The introduction of IgE caused a 
significant Id decrease, whose magnitude was proportional to 
the concentration of IgE. The LOD achieved by this assay was 
250 pM. Additionally, this study demonstrated the improved 
sensing performance of aptamer-modified devices compared 
with antibody-modified devices under similar experimental 
conditions. The higher sensitivity of aptamer-modified devices 
can be attributed to the small size of aptamers, which enables 
a larger effect of bound IgE molecules on the equilibrium 
distribution of mobile carriers in the carbon nanotubes by 
reducing the distances between IgE molecules and the 
nanotubes to a level below the Debye length (Fig. 5b).
79, 80
 
However, none of these studies involved clinical sample 
detection, which is essential for diagnostic applications. 
Ruslinda et al. demonstrated the detection of human 
immunodeficiency virus type 1 Trans-activator transcription 
(HIV-1 Tat protein) in clinical samples using an FET-based 
sensor with RNA aptamers as the recognition element (Fig. 
5c).
37
 Incubations with HIV-1 Tat protein at concentrations of 
100 nM, 10 nM and 1 nM resulted in 91 mV, 49 mV and 20 mV 
of gate potential shifts in the negative direction, indicating that 
quantitative measurements were feasible and LOD of this 
assay was beyond 1 nM. Additionally, the RNA aptamer was 
demonstrated to be highly specific to the target and cyclic 
detections were achieved, demonstrating the reusability of the 
proposed sensor. 
More recently, Goda et al. conducted a series of studies in the 
field of FET-based biosensors using aptamers as the 
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recognition element. In 2012, an assay using aptamer-
functionalized FET sensor with a gold electrode as extended 
gate was reported.
38
 As a proof-of-concept, detections of 
adenosine triphosphate (ATP) and adenosine using hairpin-
structured DNA aptamers were demonstrated. Capture of the 
target molecules led to a structural switching of the aptamer 
from closed loop to open-loop conformations and the release 
of the preloaded DNA binder (DAPI, positively charged) into 
the solution (Fig. 6a). The sensitivities achieved for ATP (below 
10 nM) and adenosine (1-10 nM) were significantly improved 
compared with previous assays. The detection of protein 
molecules using a similar platform was also demonstrated.
39
 
Herein, binding of intrinsically charged target protein led to an 
alteration in the density of charges at the gate/solution 
interface (Fig. 6b). Label-free detections of lysozyme and 
thrombin in the dynamic ranges of 15.2 – 1040 nM and 13.4 – 
1300 nM were demonstrated. The LOD achieved for lysozyme 
and thrombin were 12.0 nM and 6.7 nM, respectively. More 
recently, studies revealed that multiple-contact configurations 
could improve the binding affinity between protein and 
aptamers.
81
 Therefore, Goda et al. developed a novel aptamer-
functionalized potentiometric biosensor with improved affinity 
for the target protein (Fig. 6c).
40
 In this assay, two different 
aptamers that recognize different epitopes in thrombin were 
immobilized (in parallel or serial manners) on the sensing 
surface to capture the target via multiple contacts. As a result, 
the sensitivity of this assay was further enhanced (LOD = 5.5 
nM) compared to previous reports. 
 
Fig. 5 (a) FET-based aptasensor for adenosine. An amino-functionalized nucleic acid (named nucleic acid 5 in the study) was used as an aptamer for adenosine and another nucleic 
acid (named nucleic acid 6 in the study) was hybridized with the aptamer to amplify the signal. (From Zayats et al.,35 with permissions from American Chemical Society) (b) 
Aptamer modified CNT-FET sensor for the detection of immunoglobulin E (IgE). The smaller size of aptamer enables a significant effect of bound proteins on the equilibrium carrier 
distribution in the nanotubes as the distances between these molecules and nanotubes were less than the Debye length (From Maehashi et al.,
36
 with permissions from American 
Chemical Society) (c) Changes in gate potential induced by detection of HIV-1 Tat protein in real samples on diamond FET in 1 mM PBS (pH = 7.4). (From Ruslinda et al.,
37
 with 
permissions from Elsevier) 
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Fig. 6 (a) Conformational switching of the short hairpin (sh)-aptamer accompanied by the release of the cationic DNA binder upon detection of ATP on an FET-based sensing 
platform. (From Goda et al.,38 with permissions from Elsevier) (b) Aptamer-induced binding of protein target (e.g. lysozyme and thrombin) in an electrical double layer at the gate–
solution interface. (From Goda et al.,39 with permissions from Elsevier) (c) Electrical thrombin sensing using dual aptamer surfaces. Improved affinity between aptamers and 
thrombin due to multiple binding contacts results in enhanced sensitivity. (From Goda et al.,40 with permissions from Elsevier) 
Peptide-based sensing approaches 
As short chains of amino acid oligomers linked by peptide 
bonds, peptides have the same building blocks as proteins. 
Hence, these molecules have been used to substitute for 
proteins for clinical and diagnostic applications.
82-84
 Indeed, 
peptide-based biosensors have been proposed for detections 
of various targets, including cells,
43
 proteins,
85
 ions 
86
 and small 
molecules.
87, 88
 Distinctive advantages over natural molecules 
and other synthetic receptors have been reported for peptides. 
Primarily, peptides exhibit high affinity to particular analytes,
89
 
which can be attributed to their protein-like nature as multiple 
interactions can be observed in most binding sites of peptides. 
The high affinity allows the development of ultra-sensitive and 
highly specific peptide-based biosensors. Moreover, the 
affinity can be further enhanced by easy modifications of the 
peptides.
90
 Meanwhile, peptides have shown excellent 
intrinsic stability in harsh environments (e.g. in the presence of 
chemical and thermal denaturants). Indeed, peptides are 
significantly superior to proteins in terms of chemical and 
conformational stability due to their short-chain structures.
91
 
As a result, peptide-based biosensors exhibit significantly 
increased shelf-life compared with antibody-based ones. Also, 
peptide-based biosensors exhibit a great potential for 
multiplexed detection.
43
 In virtue of various matured protocols 
that have been reported, peptides can be chemically 
synthesized in a facile yet cost-effective way once the 
sequence information is isolated from the phage display (Fig. 
7).
92, 93
 
Nevertheless, it should be noted that conjugation of a reporter 
is typically required as peptides do not directly generate a 
measurable signal in response to a binding event in most 
assays reported.
23, 90
 In other words, label-free detection 
would be an inherent challenge for peptide-based sensing 
assays. Additionally, the selectivity of assays with peptides as 
recognition elements needs to be optimized due to the semi-
selective binding nature of peptides.
94, 95
 Indeed, many 
peptides have exhibited significant binding affinity towards 
several different cells/molecules. 
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Fig. 7 Schematic illustration of a phage display cycle for peptides. The target or a 
relevant DNA was immobilized on the surface of a microtiter plate and phages that 
display a protein binding to the surface of target molecule are kept while others are 
removed by washing. The remaining phages are then eluted and used to produce more 
phages (by bacterial infection with helper phage) so that a phage mixture enriched with 
relevant (i.e. binding) phage is obtained.96 
Since the introduction of solid phase synthesis by Merrifield,
93, 
96
 standardized and highly reproducible peptide synthesis has 
been enabled, resulting in intensive studies and applications 
(e.g. biosensors) of these synthetic molecules. Liu et al. 
presented an assay based on cyclic voltammetry for 
quantitative detection of matrilysin (MMP-7).
41
 Herein, 
peptides were immobilized on Au electrodes via self-assembly 
and cleaved in the presence of MMP-7 (Fig. 8a), resulting in 
detectable current changes. This assay was facile yet sensitive 
(LOD = 3.4 pM), and can be extended to detections of 
infectious agents. Adjémian et al. proposed a similar assay for 
rapid enzymatic measurements.
42
 Herein, peptides were 
immobilized on Au electrodes via polyethylene glycol (PEG) 
linkers (Fig. 8b) and detection of proteases (trypsin and α-
thrombin) was achieved on the peptide-functionalized 
electrodes via cyclic voltammetry. Detection of protease at 1 
nM was demonstrated on the substrate proposed and this 
assay was exceptionally rapid (75% cleavage in 1 min for 
trypsin), which could be attributed to the flexible structure of 
PEG linkers that allow easy access to cleavage sites for 
protease molecules. Nevertheless, peptide labelling (with 
ferrocene reporters) was required in both assays mentioned 
above, resulting in additional preparation procedures and 
increased cost. Hence, these assays were not ideal 
candidatures for diagnostic and clinical applications. Mannoor 
et al. presented a label-free electronic biosensor for 
quantitative detections of pathogenic bacteria via impedance 
spectroscopy.
43
 In this assay, gold microelectrode arrays 
functionalized with antimicrobial peptides were used to 
capture pathogenic bacteria such as E. coli and Salmonella and 
impedance changes were generated by the binding events (Fig. 
8c). Significantly, the LOD achieved by this assay was around 
100 cfu/mL (equivalently 1 µL
-1
), which is within the clinically 
relevant range, and the detection was demonstrated to be 
highly selective as other bacteria (e.g. Gram-negative bacteria) 
did not trigger significant signals.
97
 Additionally, the 
miniaturized sensing platform exhibited great potential for 
portable devices that can be used for in situ detections of 
infectious agents. Johnson et al. proposed a peptide-based 
label-free impedimetric biosensor for C-reactive protein (CRP), 
which is a key biomarker for cardiovascular diseases.
44
 In this 
assay, peptide-functionalized electrodes were used for CRP 
detection based on surface plasmon resonance (SPR), 
electrochemical impedance spectroscopy (EIS) and cyclic 
voltammetry. Additionally, antibody-based assay was also 
demonstrated and compared with its peptide-based peer. The 
results revealed that the small size of peptides enabled a 
larger gate accessible to the probes (Fig. 8d), resulting in a 
sharp reduction of the charge transfer resistance. More 
recently, Chen et al. introduced a peptide-functionalized 
reduced graphene oxide FET (rGO-FET) for ultra-sensitive 
detection of MMP-7. In this approach, MMP-7 specifically 
digests negatively charged polypeptides (JR2EC) immobilized 
on rGO,
98
 resulting in a significant reduction of their net 
charges (Fig. 8e). In this way, the proposed assay enabled 
label-free detection of MMP-7 at clinically relevant 
concentrations with LOD of 10 ng/mL in buffer and 40 ng/mL 
in human plasma. Additionally, the proposed assay was 
demonstrated to be highly selective as matrix 
metalloproteinase-1 (MMP-1), which is an enzyme in the same 
family as MMP-7, did not trigger detectable changes in Id. 
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Fig. 8 (a) Schematic illustration of Matrilysin detection using peptide-functionalized Au electrodes. Cleavage of immobilized peptides was triggered in the presence of target 
analyte, resulting in detectable current changes. (From Liu et al.,41 with permission from American Chemical Society) (b) Schematic illustration of protease detection using peptide-
functionalized Au electrodes. Reported-labelled peptides that were end-grafted on electrodes were cleaved in the presence of trypsin and thrombin. (From Adjémian et al.,
42
 with 
permission from American Chemical Society) (c) Schematic illustration of bacteria detection using peptide-functionalized interdigitated microelectrode array. Detection of bacteria 
was achieved via binding of target cells to the immobilized peptides. (From Mannoor et al.,43 with permission from National Academy of Sciences, USA) (d) Schematic illustration of 
CRP detection by peptide-based EIS approach. The small-sized peptide receptor allows a sharp reduction of charge transfer resistance. (From Johnson et al.,44 with permission from 
American Chemical Society) (e) Label-free detection of MMP-7 using peptide-functionalized reduced graphene oxide FET. Negatively charged peptides immobilized on rGO were 
specifically digested by MMP-7 target, resulting in a significant reduction of peptide net charge. (From Chen et al., with permission from American Chemical Society) 
Conclusions and perspectives 
This review has described and evaluated recent advances on 
electronic biosensors based on non-antibody recognition 
elements such as liposomes, aptamers and peptides. 
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Particularly, the progresses of FET-based sensing platforms 
were highlighted. These assays are ideal alternatives to 
conventional assays based on natural molecular pairs, which 
suffer from fragile and complicated functional structures, large 
molecular size and sophisticated preparation approaches. 
Comparisons between antibody-based assays and synthetic 
receptor-based ones revealed that the synthetic receptor-
based assays exhibited better sensing performance in terms of 
sensitivity. To date, detections of various analytes (including 
enzyme, virus, DNA and bacteria) at clinically relevant 
concentrations have been demonstrated using assays based on 
non-antibody recognition elements. 
Each category of assays shows different strengths and 
limitations: liposome-based assays are rapid and label-free, 
but suffer from tedious selection and modification process; 
aptamer-based assays are highly reproducible and function 
well in harsh environments, while aptamers’ sensitivity to 
hydrolytic digestion by nucleases has been an intrinsic 
drawback; peptide-based assays are sensitive and cost-
effective, but suffer from poor selectivity and additional 
labelling processes in some cases. 
Despite the great progress achieved, several issues remain to 
be solved before clinical applications of these assays. First, the 
total number of non-antibody recognition elements 
developed/discovered is still significantly lower than that of 
antibodies. This can be attributed to the fact that the discovery 
of these elements remains a trial-and-error process in most 
cases. Therefore, systematic and universal methodologies are 
urgently needed. Second, bio-sensing approaches based on 
non-antibody recognition elements have been severely limited 
by non-specific binding of target molecules, resulting in 
significantly reduced sensitivity for clinical samples. 
Additionally, molecular recognitions by aptamers and peptides 
need to be fully understood. Nevertheless, it should be noted 
that research in biosensors based on non-antibody recognition 
elements is still in its infancy and it is believed that with 
increasing efforts, these sensing assays will eventually be used 
for clinical applications and diagnostics. 
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